Cargando…
COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin
There have been limited cases linking SARS-CoV-2 infection with the development of reversible cerebral vasoconstriction syndrome (RCVS). We hereby report a rare case of RCVS in the setting of mild SARS-CoV-2 respiratory infection successfully treated with nimodipine and aspirin. SARS-CoV-2 attacks t...
Autores principales: | Mansoor, Tarab, Alsarah, Ali A., Mousavi, Hossein, Khader Eliyas, Javed, Girotra, Tarun, Hussein, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041144/ https://www.ncbi.nlm.nih.gov/pubmed/33895426 http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.105822 |
Ejemplares similares
-
Effect of Nimodipine Treatment on the Clinical Course of Reversible Cerebral Vasoconstriction Syndrome
por: Cho, Soohyun, et al.
Publicado: (2019) -
Migration of Vasoconstriction in Reversible Cerebral Vasoconstriction Syndrome
por: Hashimoto, Tetsuya, et al.
Publicado: (2022) -
Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a neuroradiological method to help differentiate from primary central nervous system vasculitis
por: Strunk, Daniel, et al.
Publicado: (2022) -
Pathophysiology of reversible cerebral vasoconstriction syndrome
por: Chen, Shih-Pin, et al.
Publicado: (2022) -
Reversible cerebral vasoconstriction syndrome: case report
por: Öz, Oğuzhan, et al.
Publicado: (2009)